ArticleJournal of clinical medicine2024

Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management.

Paola Borgia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.